Julianne R Garrison, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8080 Park Meadows Dr., Lone Treet, CO 80124 Phone: 303-346-8828 Fax: 303-346-0407 |
News Archive
Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.
EBiothera's Phase II non-small cell lung cancer (NSCLC) clinical trial evaluating Imprime PGG administered in combination with cetuximab (Erbitux), carboplatin and paclitaxel has met its goal of 90 patients and is fully enrolled, the company announced today.
A new study led by researchers at the UCLA Heart Transplant Program showed that one particular combination using tacrolimus (TAC or PrografĂ’ also known as FK506) had significant anti-rejection benefits for heart transplant patients over other combinations.
Using Medicare data, new findings from The University of Texas Medical Branch at Galveston show for the first time that the rates of long term opiate therapy - a 90-day or more supply of opioids per year - for older cancer survivors remain high for at least five years in cancer survivors.
The signs of atopy may be present long before symptoms begin, even in month-old babies, according to a new research study from Denmark. The study found that the level of urinary eosinophil protein-X (u-EPX), a marker of inflammatory cells, in newborn babies was linked to higher risk of allergic sensitization, nasal eosinophilia and eczema at six years.
› Verified 7 days ago